Gunnar Boysen

Gunnar Boysen serves as Associate Professor in the Department of Environmental Health Sciences at the University of Arkansas for Medical Sciences, where his research focuses on lifestyle-exposure-gene-interactions (LEGI) in carcinogenesis through molecular biomarker analysis.

His research centers on molecular mechanisms of environmental carcinogenesis, utilizing DNA and protein adducts to quantify internal dose exposures and metabolic pathways. Key areas include 1,3-butadiene toxicology, interindividual metabolic variability, and exposure biomarker development, bridging molecular epidemiology with environmental health risk assessment through rigorous biochemical and genomic methodologies.

Analysis of his 2021-2022 publications reveals dominant themes in DNA adduct detection methodologies (including nanopore sequencing applications), species-specific metabolic pathways of carcinogens like 1,3-butadiene and synthetic cannabinoids, and population-level biomarker variability. His work consistently integrates animal models with human studies to identify metabolic signatures relevant to lung cancer and chemical risk assessment.

Dr. Boysen actively contributes to scientific discourse as Associate Editor for Regulatory Toxicology at Frontiers in Toxicology, demonstrating sustained engagement with the toxicology research community.